TODD HOLMAN

Allopathic & Osteopathic Physicians|Allergy & Immunology LONGVIEW, TX NPI 1982607776

General Payments — all program years on this page

$392.57

  • Category: General Payments
  • Program years: PY2018
  • Record count: 21
  • As of (CMS publication): 2026-01-23

Latest program year (PY2018): $392.57 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2018) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $392.5721

By paying entity

Latest program year (PY2018) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $392.5721

Records — PY2018 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
559680011 AstraZeneca Pharmaceuticals LP $11.52 04/10/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
560161011 AstraZeneca Pharmaceuticals LP $12.28 01/31/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
560387869 AstraZeneca Pharmaceuticals LP $14.13 05/31/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
560481657 AstraZeneca Pharmaceuticals LP $13.96 04/13/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
560510289 AstraZeneca Pharmaceuticals LP $15.51 05/02/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
561398199 AstraZeneca Pharmaceuticals LP $33.26 01/31/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
562190266 AstraZeneca Pharmaceuticals LP $15.97 03/09/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
562277985 AstraZeneca Pharmaceuticals LP $11.44 04/25/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
570227307 Regeneron Healthcare Solutions, Inc. $21.93 05/22/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
573084740 Kaleo, Inc. $12.15 05/08/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
577364729 Boehringer Ingelheim Pharmaceuticals, Inc. $18.59 02/20/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
578520627 Boehringer Ingelheim Pharmaceuticals, Inc. $15.02 03/02/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
578520629 Boehringer Ingelheim Pharmaceuticals, Inc. $17.14 03/27/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
593771835 GlaxoSmithKline, LLC. $13.93 04/23/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
594047817 GlaxoSmithKline, LLC. $10.50 02/22/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
594242727 GlaxoSmithKline, LLC. $19.62 04/16/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
594836319 GlaxoSmithKline, LLC. $11.12 06/20/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
602787311 GENZYME CORPORATION $75.51 02/08/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
605288685 Mylan Specialty L.P. $11.82 03/20/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
610245775 PFIZER INC. $10.62 05/25/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
615389803 CSL Behring $26.55 04/18/2018 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.